Please use this identifier to cite or link to this item:
|Title:||Adiponectin: Obesity and Development of Different Diseases||Authors:||AMADO ISRAEL DE LA CRUZ GALINDO
Jonnathan Guadalupe Santillán Benítez
ENRIQUE MORALES AVILA
|Keywords:||adiponectin;adipokine;obesity;adipor1;adipor2;info:eu-repo/classification/cti/2||Publisher:||Annual Research & Review in Biology||Description:||Revisión bibliográfica de la relación entre adiponectina, obesidad y desarrollo de diferentes enfermedades
Adiponectin is an adipokine abundantly expressed in adipose tissue, which has been well characterized, demonstrating its beneficial effect on human health, circulates in the bloodstream in various isoforms, playing different roles in the balance of energy homeostasis. Adiponectin is an insulin sensitizing hormone that exerts its action through AdipoR1, AdipoR2 and T-cadherin receptors. AdipoR1 is abundantly expressed in muscle, whereas AdipoR2 is expressed predominantly in the liver. Adiponectin is inversely proportional to obesity, diabetes and other states of insulin resistance; this review presents current findings regarding regulation, production and biological effects. Adiponectin acts by activating AMPk (AMP-activated protein kinase) and thus the enzymatic modulation so that the signaling pathways play an important role in the regulation, in addition to the above it has been demonstrated that the deregulation in the biogenesis and function of the miRNAs contributes to the appearance and development of diverse diseases.
|Appears in Collections:||Producción|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.